RE:Hmmmmm.... Impressive digging.
now, of course, the common sense question that needs to be asked...
Why would one of the architects of the $4-$5B Vantive spin-off want to align themselves with lil ol Spectral if the Private Equity player ( assuming still a serious possibility) especially if said player had little to no interest in a high margin, bolt-on ( with FDA exclusivity) that eventually will bring in > $2B USD top line revenue annually ?
MM